|
|
|
|
|
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
|
Victoria, BC, June 21, 2021--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) announced the appointment of Dr. Brinda Balakrishnan, M.D., Ph.D., to the Company's Board of Directors. Dr. Balakrishnan is Group Vice President, Corporate and Business Development of BioMarin Pharmaceutical Inc., a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare disorders.
|
|
|
|
|
|
|
|
|
|